middle-aged and older adults. Several studies, mostly single-site case series, have found a high prevalence of SDB in patients with subacute and chronic spinal cord injury (SCI) (range, 27%-82%). [3] [4] [5] [6] The variability in estimated prevalence is related to multiple factors, including different diagnostic methods, (ie, polysomnography, home sleep apnea testing [HSAT], nocturnal oximetry), different definitions of respiratory events, and different thresholds for defining SDB (Table 1) . [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Therefore, it is difficult to make definitive statements about actual prevalence.
Several factors may influence the prevalence and type of SDB in patients with SCI/D, such as level of injury, type of injury, and associated comorbidities. First, the level of spinal injury affects the occurrence and manifestations of SDB, and patients with tetraplegia are more likely to have SDB than those patients with paraplegia. 3 In a study by Berlowitz et al, 4 the prevalence of SDB in a cohort of cervical SCI was 62% in the 4 weeks immediately postinjury and remained 60% after 1 year of follow-up. Our data also reveal a higher prevalence of SDB in patients with cervical relative to thoracic SCI (93% vs 55%, respectively). 3 Patients with cervical SCI suffer from the full continuum of derangements that impair the ability of the ventilatory system to compensate for physiologic challenges, including neuromuscular weakness, decreased lung volumes, abnormal chest wall mechanics, frequent use of CNS suppressants, and an unopposed parasympathetic system promoting airway narrowing. Second, although most studies address traumatic SCI, SDB rates are also higher in spinal cord disorders such as spinal muscular atrophy, myelomeningocele, multiple sclerosis, rheumatoid arthritis, tumors, or infections. [17] [18] [19] Type of SDB: Obstructive vs Central SDB Medication use may also contribute to increased central apnea risk. However, the use of opiate analgesics did not predict CSA in patients with SCI. 3 Conversely, another study found that baclofen use correlated with increased CSA prevalence. 6 Obstructive SDB is the most predominant type reported at all levels of SCI (Table 1) . However, based on the criteria used to score respiratory events (ie, hypopnea), many events (estimated 20%) were reported to be central in nature. 6 There are limited data on the prevalence of mixed apnea in this population. Sleep is a physiologic challenge rather than relief for the respiratory system. Sleep-related changes lead to pharyngeal narrowing, increased upper airway collapsibility, unmasking of the apneic threshold, and impaired load compensation as depicted in Figure 1 .
Respiration during non-rapid eye movement sleep is critically dependent on PCO 2 ; therefore, central apnea occurs if PCO 2 decreases below the hypocapnic apneic threshold. Central apnea rarely occurs as a single event; instead, it occurs in cycles of apnea or hypopnea, alternating with hyperpnea, reflecting the negative feedback closed-loop cycle that characterizes ventilatory chestjournal.org control. This is often described using the engineering concept of loop gain, which combines the response of the ventilatory system to changing PCO 2 (the controller or chemoreflex sensitivity) and the effectiveness of the lung/respiratory system in lowering PCO 2 in response to hyperventilation (the plant). Changes in either parameter would change the requisite magnitude of hypocapnia to reach central apnea (carbon dioxide reserve). Chemoreflex sensitivity is often invoked as a determinant of central apnea. However, plant factors, expressed by the relationship between ventilation and PCO 2 , also influence the propensity to develop central apnea. Specifically, high PCO 2 , for a given metabolic rate, promotes respiratory instability by increasing the effectiveness of the respiratory system in lowering PCO 2 in response to hyperventilation. Therefore, exaggerated sleep-related hypoventilation promotes hypocapnic central apnea by increasing plant gain via increased effectiveness of carbon dioxide elimination.
Central apnea may also influence the development of OSA because pharyngeal obstruction or narrowing develop when ventilatory drive reaches a nadir during central apnea or hypopnea. Pharyngeal collapse, combined with mucosal and gravitational factors, may impede pharyngeal opening and necessitate a substantial increase in a drive that perpetuates breathing instability.
SCI/D-Specific Pathophysiologic Factors
Established SDB risk factors, including obesity and male sex, are more common among patients with SCI/D than in the general population. 24 In addition, patients with cervical SCI/D experience multiple derangements that impair the ability of the ventilatory system to compensate for physiologic challenges of sleep, including neuromuscular weakness, small lung volume, abnormal chest wall mechanics, frequent use of central nervous system suppressants, and an unopposed parasympathetic system promoting airway narrowing. 6, 25 Additional physiologic derangements in patients with SCI/D may contribute to increased risk of central or obstructive apnea in this population. chestjournal.org increased end tidal PCO 2 , compared with thoracic SCI. Hypoventilation is noted starting at sleep onset and is independent of respiratory mechanics. 26 31, 32 The underlying mechanism of enhanced peripheral chemoresponsiveness in patients with SCI is unclear but could be because of exposure to chronic intermittent hypoxia. 33 Specifically, individuals living with SCI may experience chronic intermittent hypoxia because of decreased lung volume, impaired chest wall mechanics, retained secretions, and impaired cough. Accordingly, alleviating SDB may decrease peripheral chemoreflex sensitivity and overall chemoresponsiveness and decrease the propensity to central apnea.
Arousal Threshold: Arousal threshold is one of the physiologic traits that contributes to the pathogenesis of SDB. 24 A recent study found that arousal threshold is significantly reduced in individuals with SCI, indicating increased arousal propensity, 34 which may contribute also to the mechanism of sleep disturbances in SCI.
In summary, the combination of sleep-related hypoventilation and increased peripheral chemoresponsiveness may explain why patients with cervical SCI demonstrate increased propensity for central apnea. However, elevated Pcrit provides a physiologic explanation for increased risk of OSA in patients with cervical and thoracic SCI. Understanding the unique pathophysiologic mechanisms may inform the development of targeted therapies in this population.
Clinical Presentation and Management
Individuals living with disabilities, especially those with limited mobility, experience significant disparities in health-care services. Individuals living with SCI/D may suffer inequity in treatment of SDB as well.
Clinical Evaluation of Patients With SCI/D With Suspected SDB
Poor sleep quality, hypersomnolence, and daytime fatigue are common complaints in individuals with SCI/D. 35 SDB should be considered a potential underlying contributory factor for these symptoms. Recent data in individuals with acute cervical SCI reported that increased SDB severity was associated with worse attention, information processing, and short-term memory. 36 Despite this high rate of abnormal sleep and daytime symptoms, SDB remains underdiagnosed and undertreated in these patients. 37 Furthermore, commonly used questionnaires (eg, Berlin Questionnaire Sleep Apnea, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale) are limited in their ability to identify patients with SCI/D likely to suffer from SDB. 38 The relevance of select items on these measures is questionable for patients with limited mobility because of SCI/D. Extremely high rates of overall poor sleep quality may limit the clinical utility of screening questionnaires for SDB.
Diagnostic Testing for SDB
Patients living with SCI/D face numerous hurdles to accessing high-quality care for sleep disorders, including inadequate recognition, erroneous attribution of daytime symptoms, limited access to sleep diagnostic services, and difficulties using ventilatory support or positive airway pressure (PAP) therapy. 38 In addition, most clinical sleep laboratories are not equipped to address the needs of patients with SCI/D. Figure 2 provides a comparison between a standard sleep laboratory room in a clinical sleep laboratory and a specially equipped room that we use for conducting polysomnography in patients with SCI/D. Some of these requirements may be required for patients with limited mobility for a number of comorbid conditions. Specifically, patients with SCI/D who need polysomnography should be referred to sleep centers that have the necessary expertise and resources to care for these patients, such as wheelchair access, availability of a lift, a special wound care bed, and adequate training of staff. Hospital-based sleep centers could serve as a referral center for patients with limited mobility.
HSAT is an attractive option, especially if combined with transcutaneous carbon dioxide monitoring to identify sleep-related hypoventilation 6 ; however, HSAT devices await sufficient empirical evidence of validity and reliability of event detection without the benefit of EEG in patients with SCI/D. Alterations in the pathophysiology of SDB itself in these patients, including high rates of CSA, may limit the utility of HSAT for diagnostic purposes.
Management of SDB in Patients With SCI/D
It is estimated that two-thirds of patients with SCI/D do not require ventilatory support after recovery from the acute injury and < 10% may require long-term ventilation. 39, 40 However, there is increased risk of pulmonary complications, including delayed apnea in patients with high cervical SCI and more complete injuries. 41, 42 Therefore, it may be prudent to consider early tracheostomy and ventilation in acute high cervical SCI (complete SCI above the level of C5) and noninvasive ventilation and assisted coughing techniques in lower cervical and thoracic level injuries. 43 For patients with SCI below C4 who do not require continuous mechanical ventilation but have evidence of hypoventilation, bilevel PAP with volume-assured pressure support has been recently used and reported an improvement of nocturnal hypercapnia in 77% of patients. 44 However, there are no studies comparing PAP and bilevel PAP in patients with SCI who have SDB and nocturnal hypoventilation.
PAP therapy is the treatment of choice for patients with SCI/D with SDB. In fact, the use of PAP for SDB treatment in SCI is now recognized and recommended as a key component in standardized SCI reporting. 45 There are limited data on the acceptance of PAP treatment for patients with SCI and SDB. One study which used phone interviews found that PAP therapy was initiated in 60% of individuals with SDB. 38 Another study found that most individuals (> 90%) agreed to initiate PAP therapy. 44 Nevertheless, adherence to PAP therapy in patients with SCI/D remains a challenge despite education, follow-up, and support. 46, 47 Some factors that lead to discontinuation of therapy are related to weakness and mobility impairment to the upper extremities, mask claustrophobia, increased awakenings, nasal congestion, lack of education, and inconvenience. Many of these can be mitigated through the better nasal interface and through PAP education.
Future Directions
Increasing interest in understating the mechanism(s) of SCI/D-related sleep and respiratory disorders has identified several gaps that require further investigation. These opportunities include the pathophysiology, diagnosis, and management of SDB in this population.
Etiology of SDB: The mechanisms underlying sleeprelated hypoventilation and increased CSA risk in patients with tetraplegia require further investigation, including the mechanisms of increased chemoreflex sensitivity. Understanding these mechanisms may inform treatment of central SDB of multiple etiologies. [48] [49] [50] such as the use of daily administration of intermittent hypoxia or pharmacologic agents, which capitalizes on the intrinsic plasticity of the respiratory system to enhance ventilatory motor output and restore respiratory function via serotonin and brain derivative neutrophilic factor-dependent mechanisms. 51, 52 Conclusions SDB is common among individuals with SCI/D, particularly among those with cervical injuries. The mechanism(s) for the increased prevalence of SDB after surviving SCI are not clear yet, but evidence points toward complex pathways that include hypoventilation, upper airway collapsibility, and neuromuscular weakness. Other types of spinal cord disorders such as multiple sclerosis and other degenerative disorders that cause paralysis are important to study and assess in a large epidemiologic fashion. The current diagnostic approach of SDB in patients with SCI/D may be challenging for patients with limited mobility and high care needs. Therefore, enhancing the current diagnostic approach may be required to ensure optimal access and care quality for SDB in patients with SCI/D. Finally, PAP acceptance and adherence remain suboptimal and require additional equipment modification, provider training, or patient education. This also supports the need to develop and evaluate alternative therapies.
